Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HSV-2 Genital Herpes”

62 trials

Showing 20 of 62 results

Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Testing effectiveness (Phase 2)Study completedNCT00371592
What this trial is testing

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Who this might be right for
HIV InfectionsHerpesvirus 2, Human
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableWithdrawnNCT00682721
What this trial is testing

Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women

Who this might be right for
Bacterial VaginosisHerpes Simplex Virus Type II
University of Pittsburgh
Large-scale testing (Phase 3)Study completedNCT00465205
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Who this might be right for
HIV InfectionsHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Testing effectiveness (Phase 2)UnknownNCT03595995
What this trial is testing

Trial to Evaluate the Safety and Efficacy of UB-621

Who this might be right for
Genital Herpes
United BioPharma 80
Not applicableStudy completedNCT04205721
What this trial is testing

Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa

Who this might be right for
HSV-2 InfectionHIV InfectionsPregnancy Related
University of North Carolina, Chapel Hill 23,061
Large-scale testing (Phase 3)Study completedNCT00164424
What this trial is testing

Episodic Acyclovir Therapy for Genital Ulcers

Who this might be right for
HIV InfectionsUlcerHerpes Simplex
Centers for Disease Control and Prevention 613
Not applicableStudy completedNCT03080961
What this trial is testing

The VIBLOK SAfety and perFormancE Trial

Who this might be right for
HSV-2 InfectionGenital Herpes
CLJI Worldwide 82
Post-approval studies (Phase 4)Study completedNCT00306293
What this trial is testing

VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2

Who this might be right for
Herpes Labialis
GlaxoSmithKline 70
Post-approval studies (Phase 4)Ended earlyNCT00495716
What this trial is testing

Effect of HSV-2 Suppressive Therapy on Sexual Behavior

Who this might be right for
Genital Herpes
University of Washington 72
Large-scale testing (Phase 3)Study completedNCT00378976
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

Who this might be right for
HIV InfectionHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT02114060
What this trial is testing

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 310
Testing effectiveness (Phase 2)Study completedNCT06033261
What this trial is testing

MRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

Who this might be right for
Genital Herpes
ModernaTX, Inc. 365
Testing effectiveness (Phase 2)Study completedNCT00740584
What this trial is testing

Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.

Who this might be right for
HIV InfectionsHSV-2 Genital Herpes
Starpharma Pty Ltd 12
Testing effectiveness (Phase 2)Study completedNCT00158509
What this trial is testing

Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding

Who this might be right for
Herpes GenitalisHIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 215
Post-approval studies (Phase 4)Study completedNCT00362297
What this trial is testing

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Who this might be right for
Genital Herpes
University of Washington 31
Large-scale testing (Phase 3)Study completedNCT00076232
What this trial is testing

Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

Who this might be right for
HIV InfectionsHIV SeronegativityHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 3,682
Testing effectiveness (Phase 2)Ended earlyNCT01658826
What this trial is testing

Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

Who this might be right for
Genital Herpes
AiCuris Anti-infective Cures AG 91
Testing effectiveness (Phase 2)Study completedNCT01667341
What this trial is testing

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 143
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation